Information
A standard operating procedure is attached to this page.
You should also familiarise yourself with our background guide Facilitating pharmaceutical support to PCN designated sites for COVID-19 vaccinations before using this SOP.
Preparing the AstraZeneca COVID-19 Vaccine at PCN designated sites and end user locations
David Erskine, Director, London Medicines Information Services, Specialist Pharmacy ServicePublished Last updated See all updates
Standard Operating Procedure for preparation of AstraZeneca COVID-19 Vaccine in PCN designated sites and end user locations prior to immediate administration.
What to do if you still have questions
If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.
Change history
- Updated to further clarify wording on disposal of vaccine and vaccine packaging to prevent theft and misuse
- Updated AVH 3.1 V1.5 to V1.6 to include AZ specific images of vaccine vial and syringe.
- Amended AVH 3.2 to restore missing step in process
- Amended AVH 3.1 to align with AVH 3 in terms of wording about sterile alcohol wipes
- Updated to clarify wording on disposal of vaccine and vaccine packaging to prevent theft and misuse
- Updated AVH 3.1 to align with AVH 3 in terms of wording about removal of vaccine vials from refrigerator
- Clarification of wording about removal of vaccine vials from refrigerator
- Avoidance of pooling of vaccine overage added
- Amended needle gauge options for morbidly obese patients in accordance with PHE Guidance.
- Clarification on working under the national PGD and inclusion of extra consumables for additional doses incorporated into main text.
- Published